Sage Journals: Discover world-class research

Retricted access

Case report

First published 2024-10

Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient

Beatriz Somoza-Fernández, Vicente Escudero-Vilaplana, Roberto Collado-Borrell [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2021-4

Comparing the clinical efficacy and safety of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis

Xin Wang, Hui Yang, Xiaopeng Hu [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2014

Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison

Pui S. Tan, Benjamin Haaland, Alberto J. Montero [...]

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2025-10

Strategies for Improving Access to Effective Prostate Cancer Medications (Abiraterone and Enzalutamide) in Low- and Middle-Income Countries (LMICs): A Survey Among Nigerian Health Professionals

Omolara Fatiregun, Onyeanunam Ekeke, Egbuchilem Chisor-Wabali [...]

Cancer Control

Open access

Research article

First published 2023

Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer

Pier Vitale Nuzzo, Francesco Ravera, Calogero Saieva [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2023-8

Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide

Maria La Vecchia, Ivan Fazio, Nicolò Borsellino [...]

Tumori Journal

Open access

Review article

First published 2022-7

Prostate Cancer Drug Therapy: What Have Clinicians Missed During the COVID-19 Pandemic

M. S. Rahnama’i

American Journal of Men's Health

Open access

Review article

First published 2021

Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel

Fabio Augusto Barros Schutz, Ekaphop Sirachainan, Shanggar Kuppusamy [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2016

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer

Karim Boudadi, Emmanuel S. Antonarakis

Clinical Medicine Insights: Oncology

Free access

Research article

First published 2012-8

Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born

Michael T. Schweizer, Emmanuel S. Antonarakis

Therapeutic Advances in Urology

Search results